Nonobstructive Heart Enlargement Responds to Aficamten
01/09/2026
Introducción Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive
Expansión de cobertura para TAVR La cobertura de reemplazo aórtico transcatéter (TAVR) ha sido ampliada por el CMS. Se elimina…
Read more →
Introducción Treatment with aficamten (Myqorzo) improved exercise capacity as well as health status and symptoms in patients with symptomatic nonobstructive
Investigación reciente An investigational factor XIa inhibitor did not reduce the risk of recurrent cardiovascular (CV) events in patients with
Resumen del estudio Los pacientes con infarto de miocardio (MI) lograron un control más rápido del colesterol LDL al iniciar
For the first time, a major randomized trial was able to show that primary prevention statins did have a place
Note that some links may require registration or subscription. Abiomed flagged a heart pump controller purge cassette problem associated with